GlassScriptPhysician profile
Shannon Kasper
NPI 1457712101
$1,510.30
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $43.79 · 2022: $655 · 2023: $687 · 2024: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $812.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $811.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $521.25 | 2022-2024 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $155.26 | 2022-2023 | Jardiance |
| Janssen Pharmaceuticals, INC | $154.84 | 2021-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $141.33 | 2022-2024 | Verquvo |
| Pfizer INC. | $97.02 | 2022-2023 | |
| Novo Nordisk INC | $93.47 | 2023-2024 | Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $92.50 | 2022-2024 | |
| Edwards Lifesciences Corporation | $82.60 | 2022-2023 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| E.R. Squibb & Sons, L.L.C. | $52.74 | 2023 | Eliquis, Camzyos |
| Amgen INC. | $39.18 | 2023 | Repatha |
| Kiniksa Pharmaceuticals, LTD. | $26.08 | 2023 | Arcalyst |
| Kiniksa Pharmaceuticals International, Plc | $22.71 | 2024 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $13.97 | 2022 | |
| Boston Scientific Corporation | $12.35 | 2022 | |
| Ucb, INC. | $5.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Kasper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.